Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage (Seite 2143)

[nicolani]

Antwort auf Beitrag Nr.: 64.451.993 von mfierke am 17.07.20 17:16:22

ja was tun, ich könnte mir den ar... aufreissen, hier zu früh so viel rausgegeben zu haben, aber nichtsdestotrotz richtig gut geschnappt! was denkst du, morgen die hälfte rausgeben!

[schnitzala]

bin hier Ende Februar bei 10€ eingestiegen und paar Tage später ausgestoppt worden :-(

[mfierke]

Antwort auf Beitrag Nr.: 64.451.723 von schnitzala am 17.07.20 17:00:13

nein news gibt es nicht, die steigt wie Teufel. Für mich die 2. Wirecard. und hoffe das das nicht stimmt.

[schnitzala]

Gibt's News?

[mfierke]

Den Zukauf reingestellt. Jetzt hoffe ich das das nach 7 uhr morgen klappt.

[Magnetfeldfredy]

In animal models, Novavax's vaccine is producing far more antibodies than any other candidate. And it's not even close. "We are seeing neutralizing titers in the 10,000 range in non-human primates," Gregory Glenn, president of research and development at Novavax said. AstraZeneca and Oxford University are reporting neutralizing antibody titers of around 40 in animal studies, while Sinovac reported neutralizing antibody titers up to 60 in animals. 3. Novavax has arguably the best flu vaccine Novavax has proven that its vaccine platform works with NanoFlu, its influenza vaccine candidate that has zoomed through clinical trials, defeating the market-leading vaccine from Sanofi in head-to-head trials.

Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage | wallstreet-online.de - Vollständige Diskussion unter:
https://www.wallstreet-online.de/diskussion/1149910-1381-139…

[Magnetfeldfredy]

Ein Einstieg jetzt, keine Ahnung aber drin bleiben ja, Novavax scheint denbest wirkenden Impstoff zu haben, wenn ja, US Dollar 500:

3 Green Flags for Novavax's Future
There are good reasons to consider this small biotech an emerging favorite in the COVID-19 vaccine race.
Taylor Carmichael
Taylor Carmichael
(TMFSaintCroix)
Jul 10, 2020 at 1:07PM
Author Bio

Tiny Novavax (NASDAQ:NVAX) has emerged as one of the strongest stocks in the first six months of 2020, running up an astounding 2,300%. Most of that surge has been due to excitement about NVX-CoV2373, the company's COVID-19 vaccine candidate. Here are three reasons why the market has been so bullish about Novavax in 2020.
COVID-19 vaccine in gloved hand

Image source: Getty Images
1. Major financial support from major outsiders

Back in May, the global nonprofit Coalition for Epidemic Preparedness Innovations invested $388 million in Novavax's vaccine candidate for COVID-19. Last week, the U.S. government agreed to pay the company $1.6 billion through Operation Warp Speed to help develop it. With almost $2 billion of free money in the bank, Novavax can now easily compete with all the big pharmaceutical players. And at a market cap of under $6 billion, it's trading at less than three times its cash.
2. Better immunogenicity than rival candidates (so far)

In animal models, Novavax's vaccine is producing far more antibodies than any other candidate. And it's not even close. "We are seeing neutralizing titers in the 10,000 range in non-human primates," Gregory Glenn, president of research and development at Novavax said. AstraZeneca and Oxford University are reporting neutralizing antibody titers of around 40 in animal studies, while Sinovac reported neutralizing antibody titers up to 60 in animals.
3. Novavax has arguably the best flu vaccine

Novavax has proven that its vaccine platform works with NanoFlu, its influenza vaccine candidate that has zoomed through clinical trials, defeating the market-leading vaccine from Sanofi in head-to-head trials.

With $2 billion in cash and a strong vaccine platform, it might be the odds-on favorite right now.

10 Top Stocks we like better than Novavax, Inc.

When investing geniuses David and Tom Gardner have a stock tip, it can literally pay to listen. After all, they have consistently beaten the market for over 25 years!

David and Tom just revealed what they believe are their ten Top Stocks for investors to buy right now… and Novavax, Inc. wasn't one of them! That's right -- they think these 10 stocks may be even better buys.

See the 10 Top Stocks

[hn068]

Antwort auf Beitrag Nr.: 64.322.471 von Roland85 am 07.07.20 16:45:13

Das dachte ich mir bei 45€ auch und bin rein

[Roland85]

Ob ein Einstieg jetzt noch Sinn macht?

[Magnetfeldfredy]

Von US Dollar 3,54 im Januar auf heute US Dollar 110,00 und keine Ende in Sicht, Novavax scheint den heiligen Gral zum Corona-Impfstoff zu haben und kann sich locker noch verdoppeln, sollte der Impfstoff wirken, wonach es aussieht!
Wer gibt schon 1,6 Milliarden ohne nähere Hintergrundinformationen zu haben!

Ich bin von der "Fastpleite" von Novavax in den Börsenhimmel gekommen, jedoch ist der Kurs erst bei ca. 5 US Dollar wenn man den Reversesplit von 1:20 berücksichtigt!